← All patents

US10576096B2

Tumor-selective combination therapy

University of Texas System

Abstract

The therapies described herein can be selectively lethal toward a variety of different cancer cell types and cancer conditions in a subject. The combination therapies described herein can be useful for the management, treatment, control, or adjunct treatment of diseases, where the selective …

University
University of Texas System
Assignee
The Board Of Regents Of The University Of Texas System
Inventor
Paul J. Hergenrother
Priority date
April 09, 2013
Filing date
December 06, 2017
Grant date
March 03, 2020
Publication date
March 03, 2020
Language
en
Metadata fetched
August 29, 2026 00:26